{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T11:55:46Z","timestamp":1785239746030,"version":"3.55.0"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.cca.2022.12.022","type":"journal-article","created":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T02:04:30Z","timestamp":1671674670000},"page":"259-265","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Preanalytical considerations in parathyroid hormone measurement"],"prefix":"10.1016","volume":"539","author":[{"given":"Jin","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danni","family":"Mu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danchen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinqi","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.cca.2022.12.022_b0005","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1373\/clinchem.2009.134643","article-title":"Quantification of serum 1\u201384 parathyroid hormone in patients with hyperparathyroidism by immunocapture in situ digestion liquid chromatography-tandem mass spectrometry","volume":"56","author":"Kumar","year":"2010","journal-title":"Clin. Chem."},{"issue":"4","key":"10.1016\/j.cca.2022.12.022_b0010","doi-asserted-by":"crossref","first-page":"569","DOI":"10.2215\/CJN.06620617","article-title":"Association of Nonoxidized Parathyroid Hormone with Cardiovascular and Kidney Disease Outcomes in Chronic Kidney Disease","volume":"13","author":"Seiler-Mussler","year":"2018","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"5","key":"10.1016\/j.cca.2022.12.022_b0015","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1073\/pnas.49.5.613","article-title":"Immunoassay of Bovine and Human Parathyroid Hormone","volume":"49","author":"Berson","year":"1963","journal-title":"PNAS"},{"issue":"8","key":"10.1016\/j.cca.2022.12.022_b0020","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1093\/clinchem\/33.8.1364","article-title":"Highly sensitive two-site immunoradiometric assay of parathyrin, and its clinical utility in evaluating patients with hypercalcemia","volume":"33","author":"Nussbaum","year":"1987","journal-title":"Clin. Chem."},{"key":"10.1016\/j.cca.2022.12.022_b0025","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/bs.acc.2020.06.005","article-title":"Parathyroid hormone","volume":"101","author":"Leung","year":"2021","journal-title":"Adv. Clin. Chem."},{"key":"10.1016\/j.cca.2022.12.022_b0030","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.clinbiochem.2021.04.018","article-title":"Parathyroid hormone measurement in chronic kidney disease: Impact of inter-method variability on mineral bone disease assessment","volume":"94","author":"White","year":"2021","journal-title":"Clin. Biochem."},{"issue":"9","key":"10.1016\/j.cca.2022.12.022_b0035","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1515\/cclm-2018-0217","article-title":"Trueness, precision and stability of the LIAISON 1\u201384 parathyroid hormone (PTH) third-generation assay: comparison to existing intact PTH assays","volume":"56","author":"Valcour","year":"2018","journal-title":"Clin. Chem. Lab. Med."},{"issue":"3","key":"10.1016\/j.cca.2022.12.022_b0040","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1111\/j.1523-1755.2005.00493.x","article-title":"Structure of non-(1\u201384) PTH fragments secreted by parathyroid glands in primary and secondary hyperparathyroidism","volume":"68","author":"D'Amour","year":"2005","journal-title":"Kidney Int."},{"issue":"4","key":"10.1016\/j.cca.2022.12.022_b0045","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1093\/clinchem\/44.4.805","article-title":"A non-(1\u201384) circulating parathyroid hormone (PTH) fragment interferes significantly with intact PTH commercial assay measurements in uremic samples","volume":"44","author":"Lepage","year":"1998","journal-title":"Clin. Chem."},{"issue":"3","key":"10.1016\/j.cca.2022.12.022_b0050","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1373\/clinchem.2014.235440","article-title":"Mass Spectrometric Immunoassay Raises Doubt for the Existence of Parathyroid Hormone Fragment 7\u201384","volume":"63","author":"Singh","year":"2015","journal-title":"Clin. Chem."},{"issue":"6","key":"10.1016\/j.cca.2022.12.022_b0055","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1093\/clinchem\/hvab013","article-title":"Chemical Characterization and Quantification of Circulating Intact PTH and PTH Fragments by High-Resolution Mass Spectrometry in Chronic Renal Failure","volume":"67","author":"Kritmetapak","year":"2021","journal-title":"Clin. Chem."},{"issue":"6","key":"10.1016\/j.cca.2022.12.022_b0060","doi-asserted-by":"crossref","first-page":"422","DOI":"10.7326\/M17-2640","article-title":"Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder: Synopsis of the Kidney Disease: Improving Global Outcomes 2017 Clinical Practice Guideline Update","volume":"168","author":"Ketteler","year":"2018","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.cca.2022.12.022_b0065","doi-asserted-by":"crossref","first-page":"5496710","DOI":"10.1155\/2019\/5496710","article-title":"Parathyroid Hormone Measurement in Chronic Kidney Disease: From Basics to Clinical Implications","volume":"2019","author":"Kritmetapak","year":"2019","journal-title":"Int J Nephrol"},{"issue":"3","key":"10.1016\/j.cca.2022.12.022_b0070","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1093\/ndt\/gfz163","article-title":"What does a PTH of 300 pg\/mL actually mean?","volume":"36","author":"Cavalier","year":"2021","journal-title":"Nephrol. Dial. Transplant."},{"issue":"11","key":"10.1016\/j.cca.2022.12.022_b0075","doi-asserted-by":"crossref","first-page":"4287","DOI":"10.1210\/jcem.84.11.6236","article-title":"A novel immunoradiometric assay detects full-length human PTH but not amino-terminally truncated fragments: implications for PTH measurements in renal failure","volume":"84","author":"John","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"18","key":"10.1016\/j.cca.2022.12.022_b0080","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1016\/j.clinbiochem.2012.08.006","article-title":"Clinical evaluation of two novel biointact PTH(1\u201384) assays in hemodialysis patients","volume":"45","author":"Hecking","year":"2012","journal-title":"Clin. Biochem."},{"issue":"6","key":"10.1016\/j.cca.2022.12.022_b0085","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1210\/jc.2014-4023","article-title":"A Case With Immunoassay Interferences in the Measurement of Multiple Hormones","volume":"100","author":"Gulbahar","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"Suppl 1","key":"10.1016\/j.cca.2022.12.022_b0090","doi-asserted-by":"crossref","first-page":"2","DOI":"10.4158\/EP10297.RA","article-title":"The parathyroid hormone assay","volume":"17","author":"Rodgers","year":"2011","journal-title":"Endocr. Pract."},{"issue":"12","key":"10.1016\/j.cca.2022.12.022_b0095","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1507\/endocrj.EJ20-0349","article-title":"Heterophile antibody interference associated with natural killer cell therapy","volume":"67","author":"Kim","year":"2020","journal-title":"Endocr. J."},{"issue":"1\u20132","key":"10.1016\/j.cca.2022.12.022_b0100","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.cca.2007.08.019","article-title":"False positive PTH results: an easy strategy to test and detect analytical interferences in routine practice","volume":"387","author":"Cavalier","year":"2008","journal-title":"Clin. Chim. Acta"},{"issue":"2","key":"10.1016\/j.cca.2022.12.022_b0105","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.4158\/EP10235.CR","article-title":"Falsely elevated plasma parathyroid hormone level mimicking tertiary hyperparathyroidism","volume":"17","author":"Levin","year":"2011","journal-title":"Endocr. Pract."},{"issue":"8","key":"10.1016\/j.cca.2022.12.022_b0110","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1002\/ccr3.1664","article-title":"Normocalcemia but still elevated parathyroid hormone levels after parathyroidectomy","volume":"6","author":"van der Doelen","year":"2018","journal-title":"Clin Case Rep"},{"issue":"5\u20136","key":"10.1016\/j.cca.2022.12.022_b0115","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.cca.2009.12.006","article-title":"Prevalence of human anti-mouse antibodies (HAMAs) in routine examinations","volume":"411","author":"Koshida","year":"2010","journal-title":"Clin. Chim. Acta"},{"issue":"3","key":"10.1016\/j.cca.2022.12.022_b0120","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/TP.0b013e31819575a1","article-title":"Human anti-mouse antibodies interferences in Elecsys PTH assay after OKT3 treatment","volume":"87","author":"Cavalier","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.cca.2022.12.022_b0125","doi-asserted-by":"crossref","unstructured":"S. Oh, J.H. Lee, K. Kwack, S.W. Choi, Natural Killer Cell Therapy: A New Treatment Paradigm for Solid Tumors, Cancers (Basel) 11(10) (2019).","DOI":"10.3390\/cancers11101534"},{"issue":"10","key":"10.1016\/j.cca.2022.12.022_b0130","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1007\/s00198-021-05950-2","article-title":"Asymptomatic elevated parathyroid hormone level due to immunoassay interference","volume":"32","author":"Zanchetta","year":"2021","journal-title":"Osteoporos Int."},{"issue":"12","key":"10.1016\/j.cca.2022.12.022_b0135","doi-asserted-by":"crossref","first-page":"5840","DOI":"10.1210\/jc.2019-01321","article-title":"PTH Immunoassay Interference Due to Human Anti-Mouse Antibodies in a Subject With Obesity With Normal Parathyroid Function","volume":"104","author":"Laudes","year":"2019","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.cca.2022.12.022_b0140","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1093\/clinchem\/37.5.625","article-title":"The biotin-(strept)avidin system: principles and applications in biotechnology","volume":"37","author":"Diamandis","year":"1991","journal-title":"Clin. Chem."},{"key":"10.1016\/j.cca.2022.12.022_b0145","series-title":"Biotin Deficiency","author":"Saleem","year":"2022"},{"issue":"3","key":"10.1016\/j.cca.2022.12.022_b0150","doi-asserted-by":"crossref","first-page":"451","DOI":"10.4158\/EP12158.OR","article-title":"Falsely low parathyroid hormone secondary to biotin interference: a case series","volume":"19","author":"Waghray","year":"2013","journal-title":"Endocr. Pract."},{"issue":"6","key":"10.1016\/j.cca.2022.12.022_b0155","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1515\/cclm-2016-1183","article-title":"High-dose biotin therapy leading to false biochemical endocrine profiles: validation of a simple method to overcome biotin interference","volume":"55","author":"Piketty","year":"2017","journal-title":"Clin. Chem. Lab. Med."},{"issue":"9","key":"10.1016\/j.cca.2022.12.022_b0160","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1373\/clinchem.2008.121921","article-title":"A case of renal osteodystrophy with unexpected serum intact parathyroid hormone concentrations","volume":"55","author":"Meany","year":"2009","journal-title":"Clin. Chem."},{"issue":"4","key":"10.1016\/j.cca.2022.12.022_b0165","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1093\/ckj\/sfz134","article-title":"Biotin supplement interference with immunoassays for parathyroid hormone and 25-hydroxyvitamin D in a patient with metabolic bone disease on maintenance hemodialysis","volume":"13","author":"Plasse","year":"2020","journal-title":"Clin. Kidney J."},{"key":"10.1016\/j.cca.2022.12.022_b0170","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.clinbiochem.2021.10.011","article-title":"Serum biotin interference: A troublemaker in hormone immunoassays","volume":"99","author":"\u00d6nc\u00fcl","year":"2022","journal-title":"Clin. Biochem."},{"issue":"3","key":"10.1016\/j.cca.2022.12.022_b0175","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1159\/000183149","article-title":"Biotin in the management of uremic neurologic disorders","volume":"36","author":"Yatzidis","year":"1984","journal-title":"Nephron"},{"issue":"10","key":"10.1016\/j.cca.2022.12.022_b0180","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/0753-3322(90)90171-5","article-title":"Biotin for diabetic peripheral neuropathy","volume":"44","author":"Koutsikos","year":"1990","journal-title":"Biomed. Pharmacother."},{"issue":"4","key":"10.1016\/j.cca.2022.12.022_b0185","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.jaad.2020.04.123","article-title":"Dietary supplements in dermatology: A review of the evidence for zinc, biotin, vitamin D, nicotinamide, and Polypodium","volume":"84","author":"Thompson","year":"2021","journal-title":"J. Am. Acad. Dermatol."},{"issue":"8","key":"10.1016\/j.cca.2022.12.022_b0190","doi-asserted-by":"crossref","first-page":"989","DOI":"10.4158\/EP171761.RA","article-title":"Biotin Interference with Routine Clinical Immunoassays: Understand the Causes and Mitigate the Risks","volume":"23","author":"Samarasinghe","year":"2017","journal-title":"Endocr. Pract."},{"issue":"7","key":"10.1016\/j.cca.2022.12.022_b0195","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1056\/NEJMc1602096","article-title":"Biotin Treatment Mimicking Graves' Disease","volume":"375","author":"Kummer","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.cca.2022.12.022_b0200","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1210\/jc.2016-1971","article-title":"Factitious Graves' Disease Due to Biotin Immunoassay Interference-A Case and Review of the Literature","volume":"101","author":"Elston","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.cca.2022.12.022_b0205","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1080\/17843286.2020.1780770","article-title":"Sense and nonsense concerning biotin interference in laboratory tests","volume":"77","author":"Moerman","year":"2022","journal-title":"Acta Clin. Belg."},{"issue":"6","key":"10.1016\/j.cca.2022.12.022_b0210","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1515\/cclm-2016-0606","article-title":"False biochemical diagnosis of hyperthyroidism in streptavidin-biotin-based immunoassays: the problem of biotin intake and related interferences","volume":"55","author":"Piketty","year":"2017","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.cca.2022.12.022_b0215","doi-asserted-by":"crossref","unstructured":"J. Favresse, J.L. Bayart, A. Stoefs, D. Gheldof, J. Douxfils, J.M. Dogne, D. Gruson, Neutralization of biotin interference: preliminary evaluation of the VeraTest Biotin, VeraPrep Biotin and BioT-Filter(R), Clin Chem Lab Med 58(8) (2020) e130-e133.","DOI":"10.1515\/cclm-2019-1121"},{"issue":"2","key":"10.1016\/j.cca.2022.12.022_b0220","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.msard.2015.01.005","article-title":"High doses of biotin in chronic progressive multiple sclerosis: a pilot study","volume":"4","author":"Sedel","year":"2015","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"1","key":"10.1016\/j.cca.2022.12.022_b0225","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/MOP.0b013e328335107f","article-title":"Acrodermatitis due to nutritional deficiency","volume":"22","author":"Gehrig","year":"2010","journal-title":"Curr. Opin. Pediatr."},{"issue":"5","key":"10.1016\/j.cca.2022.12.022_b0230","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1139\/cjpp-2014-0479","article-title":"Vitamins and their derivatives in the prevention and treatment of metabolic syndrome diseases (diabetes)","volume":"93","author":"Dakshinamurti","year":"2015","journal-title":"Can. J. Physiol. Pharmacol."},{"issue":"12","key":"10.1016\/j.cca.2022.12.022_b0235","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1001\/jama.2017.13705","article-title":"Association of Biotin Ingestion With Performance of Hormone and Nonhormone Assays in Healthy Adults","volume":"318","author":"Li","year":"2017","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.cca.2022.12.022_b0240","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.cca.2020.03.020","article-title":"Oxidation of parathyroid hormone","volume":"506","author":"Ursem","year":"2020","journal-title":"Clin. Chim. Acta"},{"issue":"12","key":"10.1016\/j.cca.2022.12.022_b0245","doi-asserted-by":"crossref","first-page":"4744","DOI":"10.1210\/jc.2013-2139","article-title":"Nonoxidized, biologically active parathyroid hormone determines mortality in hemodialysis patients","volume":"98","author":"Tepel","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.cca.2022.12.022_b0250","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.kint.2020.12.024","article-title":"Non-oxidized parathyroid hormone (PTH) measured by current method is not superior to total PTH in assessing bone turnover in chronic kidney disease","volume":"99","author":"Ursem","year":"2021","journal-title":"Kidney Int."},{"key":"10.1016\/j.cca.2022.12.022_b0255","doi-asserted-by":"crossref","unstructured":"S. Zeng, U. Querfeld, M. Feger, D. Haffner, A.A. Hasan, C. Chu, T. Slowinski, T. Bernd Dschietzig, F. Schafer, Y. Xiong, B. Zhang, S. Rausch, K. Horvathova, F. Lang, B. Karl Kramer, M. Foller, B. Hocher, Relationship between GFR, intact PTH, oxidized PTH, non-oxidized PTH as well as FGF23 in patients with CKD, FASEB J 34(11) (2020) 15269-15281.","DOI":"10.1096\/fj.202000596R"},{"issue":"7","key":"10.1016\/j.cca.2022.12.022_b0260","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1093\/ndt\/gfg074","article-title":"Oxidative stress in end-stage renal disease: an emerging threat to patient outcome","volume":"18","author":"Locatelli","year":"2003","journal-title":"Nephrol. Dial. Transplant."},{"issue":"7","key":"10.1016\/j.cca.2022.12.022_b0265","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1161\/01.CIR.0000050628.11305.30","article-title":"The antioxidant acetylcysteine reduces cardiovascular events in patients with end-stage renal failure: a randomized, controlled trial","volume":"107","author":"Tepel","year":"2003","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.cca.2022.12.022_b0270","doi-asserted-by":"crossref","first-page":"e40242","DOI":"10.1371\/journal.pone.0040242","article-title":"Measuring parathyroid hormone (PTH) in patients with oxidative stress\u2013do we need a fourth generation parathyroid hormone assay?","volume":"7","author":"Hocher","year":"2012","journal-title":"PLoS One"},{"issue":"4\u20135","key":"10.1016\/j.cca.2022.12.022_b0275","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1159\/000350149","article-title":"Modeling of oxidized PTH (oxPTH) and non-oxidized PTH (n-oxPTH) receptor binding and relationship of oxidized to non-oxidized PTH in children with chronic renal failure, adult patients on hemodialysis and kidney transplant recipients","volume":"37","author":"Hocher","year":"2013","journal-title":"Kidney Blood Press. Res."},{"issue":"2","key":"10.1016\/j.cca.2022.12.022_b0280","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1515\/cclm-2017-0313","article-title":"Oxidation of PTH: in vivo feature or effect of preanalytical conditions?","volume":"56","author":"Ursem","year":"2018","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.cca.2022.12.022_b0285","doi-asserted-by":"crossref","unstructured":"H. Komaba, Y. Takeda, J. Shin, R. Tanaka, T. Kakuta, Y. Tominaga, M. Fukagawa, Reversed whole PTH\/intact PTH ratio as an indicator of marked parathyroid enlargement: five case studies and a literature review, NDT Plus 1(Suppl 3) (2008) iii54-iii58.","DOI":"10.1093\/ndtplus\/sfn088"},{"issue":"6","key":"10.1016\/j.cca.2022.12.022_b0290","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/j.1365-2265.2005.02286.x","article-title":"Overproduction of an amino-terminal form of PTH distinct from human PTH(1\u201384) in a case of severe primary hyperparathyroidism: influence of medical treatment and surgery","volume":"62","author":"Rakel","year":"2005","journal-title":"Clin. Endocrinol."},{"issue":"1","key":"10.1016\/j.cca.2022.12.022_b0295","doi-asserted-by":"crossref","first-page":"69","DOI":"10.5414\/CNP64069","article-title":"Normalization of reversed bio-intact-PTH(1\u201384)\/intact-PTH ratio after parathyroidectomy in a patient with severe secondary hyperparathyroidism","volume":"64","author":"Tanaka","year":"2005","journal-title":"Clin. Nephrol."},{"issue":"4","key":"10.1016\/j.cca.2022.12.022_b0300","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/j.1365-2265.2008.03408.x","article-title":"High third generation\/second generation PTH ratio in a patient with parathyroid carcinoma: clinical utility of third generation\/second generation PTH ratio in patients with primary hyperparathyroidism","volume":"70","author":"Caron","year":"2009","journal-title":"Clin. Endocrinol."},{"issue":"6","key":"10.1016\/j.cca.2022.12.022_b0305","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1111\/j.1365-2265.2011.04021.x","article-title":"Nontruncated amino-terminal parathyroid hormone overproduction in two patients with parathyroid carcinoma: a possible link to HRPT2 gene inactivation","volume":"74","author":"Caron","year":"2011","journal-title":"Clin. Endocrinol."},{"issue":"3","key":"10.1016\/j.cca.2022.12.022_b0310","doi-asserted-by":"crossref","first-page":"E453","DOI":"10.1210\/jc.2013-3730","article-title":"The third\/second generation PTH assay ratio as a marker for parathyroid carcinoma: evaluation using an automated platform","volume":"99","author":"Cavalier","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"8","key":"10.1016\/j.cca.2022.12.022_b0315","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1373\/clinchem.2007.085506","article-title":"An N-terminal molecular form of parathyroid hormone (PTH) distinct from hPTH(1 84) is overproduced in parathyroid carcinoma","volume":"53","author":"Rubin","year":"2007","journal-title":"Clin. Chem."},{"issue":"4","key":"10.1016\/j.cca.2022.12.022_b0320","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1093\/ckj\/sft061","article-title":"Decreased expression of calcium-sensing receptor and parafibromin in secondary hyperparathyroidism with an abnormal whole PTH\/intact PTH ratio","volume":"6","author":"Yamada","year":"2013","journal-title":"Clin. Kidney J."},{"issue":"3","key":"10.1016\/j.cca.2022.12.022_b0325","doi-asserted-by":"crossref","first-page":"525","DOI":"10.2215\/CJN.01391005","article-title":"Overproduction and secretion of a novel amino-terminal form of parathyroid hormone from a severe type of parathyroid hyperplasia in uremia","volume":"1","author":"Arakawa","year":"2006","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"8","key":"10.1016\/j.cca.2022.12.022_b0330","doi-asserted-by":"crossref","first-page":"3745","DOI":"10.1210\/jc.2009-2791","article-title":"The ratio of parathyroid hormone as measured by third- and second-generation assays as a marker for parathyroid carcinoma","volume":"95","author":"Cavalier","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"8","key":"10.1016\/j.cca.2022.12.022_b0335","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1515\/cclm-2016-0914","article-title":"Parathormone stability in hemodialyzed patients and healthy subjects: comparison on non-centrifuged EDTA and serum samples with second- and third-generation assays","volume":"55","author":"Schleck","year":"2017","journal-title":"Clin. Chem. Lab. Med."},{"issue":"6","key":"10.1016\/j.cca.2022.12.022_b0340","doi-asserted-by":"crossref","first-page":"e23771","DOI":"10.1002\/jcla.23771","article-title":"Stability and validity of intact parathyroid hormone levels in different sample types and storage conditions","volume":"35","author":"Khalil","year":"2021","journal-title":"J. Clin. Lab. Anal."},{"issue":"6","key":"10.1016\/j.cca.2022.12.022_b0345","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.22144","article-title":"The effect of different protease inhibitors on stability of parathyroid hormone, insulin, and prolactin levels under different lag times and storage conditions until analysis","volume":"31","author":"Baykan","year":"2017","journal-title":"J. Clin. Lab. Anal."},{"issue":"10","key":"10.1016\/j.cca.2022.12.022_b0350","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1515\/cclm-2013-0315","article-title":"Sampling and storage conditions influencing the measurement of parathyroid hormone in blood samples: a systematic review","volume":"51","author":"Hanon","year":"2013","journal-title":"Clin. Chem. Lab. Med."},{"issue":"2","key":"10.1016\/j.cca.2022.12.022_b0355","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1373\/clinchem.2009.137323","article-title":"Selected reaction monitoring-mass spectrometric immunoassay responsive to parathyroid hormone and related variants","volume":"56","author":"Lopez","year":"2010","journal-title":"Clin. Chem."},{"issue":"11","key":"10.1016\/j.cca.2022.12.022_b0360","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1093\/clinchem\/hvac135","article-title":"Validation of an LC-MS\/MS Method Using Solid-Phase Extraction for the Quantification of 1\u201384 Parathyroid Hormone: Toward a Candidate Reference Measurement Procedure","volume":"68","author":"Farre-Segura","year":"2022","journal-title":"Clin. Chem."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898122014243?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898122014243?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T15:10:59Z","timestamp":1757862659000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898122014243"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":72,"alternative-id":["S0009898122014243"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2022.12.022","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preanalytical considerations in parathyroid hormone measurement","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2022.12.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}